The postpartum depression management market is projected to grow from USD 128.7 million in 2025 to USD 186.9 million by 2035, at a CAGR of 3.8%. Anti-Depressant Drugs will dominate with a 38.2% market share, while hospital pharmacies will lead the distribution channel segment with a 46.7% share.